{"id":"W4403454624","doi":"10.1016/j.jacadv.2024.101335","title":"Apixaban and Limiting Aspirin for Patients With Atrial Fibrillation, Percutaneous Coronary Intervention, and Multimorbidity","year":2024,"lang":"en","type":"article","venue":"JACC Advances","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"Canadian VIGOUR Centre; University of Alberta","funders":"Pfizer; Bristol-Myers Squibb","keywords":"Aspirin; Medicine; Atrial fibrillation; Percutaneous coronary intervention; Limiting; Apixaban; Cardiology; Internal medicine; Antithrombins; Intensive care medicine; Warfarin; Rivaroxaban; Myocardial infarction; Heparin","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009429392,0.0001110729,0.0001768091,0.00007198862,0.00009744197,0.0000581515,0.00001758936,0.00003390228,0.00002856355],"category_scores_gemma":[0.0001253328,0.00008340491,0.00007720359,0.0000759805,0.00004757965,0.0002882973,0.00003159001,0.00004280173,0.000002805556],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00002142652,"about_ca_system_score_gemma":0.00001055115,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00000411791,"about_ca_topic_score_gemma":0.000008368451,"domain_scores_codex":[0.9993079,0.00001480434,0.0001982864,0.0002402327,0.0001250525,0.0001137287],"domain_scores_gemma":[0.999498,0.0002580239,0.00005704228,0.00006714946,0.00006832668,0.00005145207],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.000556809,0.000002651773,0.7851709,0.0004581351,0.00008536778,0.000009091844,0.0001147954,0.00006267111,0.00001731475,0.000271287,0.00007498978,0.2131761],"study_design_scores_gemma":[0.004674056,0.001574435,0.7897882,0.0005845527,0.0004442298,0.00008911172,0.0003158087,0.007264574,0.00003067754,0.001191958,0.1937074,0.000335004],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9923713,0.00444913,0.001264039,0.000547597,0.0003383171,0.000758829,0.00001976873,0.0001019624,0.0001491155],"genre_scores_gemma":[0.9933063,0.0003449129,0.004634473,0.00002736081,0.0009071563,0.000001397304,0.0001038041,0.00001811556,0.0006564541],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.212841,"threshold_uncertainty_score":0.3401153,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02966600883032382,"score_gpt":0.3268569386952054,"score_spread":0.2971909298648816,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}